Skip to main content



Language(s) Spoken

English; Mandarin

Joined Kelsey-Seybold

August 2015

Accepting New Patients?


​​​Profes​​​sional Background 

After finishing his coursework at Baylor College of ​Medicine, Dr. Ho completed a residency in Urology at Baylor College of Medicine, and a fellowship in urologic oncology at The University of Texas M.D. Anderson Cancer Center. 

Professio​​​nal Associations 

Dr. Ho is a member of the Texas Medical Association, the American Urological Association and the American Medical Association. 

Hob​​bies and Interests

He enjoys photog​raphy and traveling.

Fu​n Facts

Dr. Ho’s father has always been his role model, and as a child, he wanted to be a doctor. The best advice he has ever received was “Never stop trying to be better.” 

Dr. Ho’s favorite dessert is bananas Foster, favorite medical television show is “ER,” favorite historical figure is Thomas Jefferson and favorite musician is Phoenix. The most interesting place he has ever visited is Bora Bora.​
​I believe that patient care should be individualized based on each patient’s disease, medical history and personal wishes.  It’s my responsibility to provide my patients with a comprehensive background of their disease and treatment options to assist them in making the best decisions for themselves.


​​​​​​​​​​​​By Phone

Our Contact Center is here to serve you, 24 hours a day, 7 days a week.


Awards & Recognitions

​Dr. Ho received the Bladder Cancer Advocacy Network (BCAN) John Quale Travel Fellowship award. He was also recognized as the Scott Department of Urology Outstanding Resident Teacher of the Year Award. He was a Urology Care Foundation Research Scholars Program recipient, earned a Killson Education Foundation Fund Scholarship at Baylor College of Medicine and also received the Arnold Award For Outstanding Medical Student.


  • In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy Rikiya Taoka, Stephen B Williams, Philip L Ho, Ashish M Kamat Canadian Urological Association Journal, March 2015; E109
  • Immune Therapies in Non-Muscle Invasive Bladder Cancer Philip L Ho, Stephen B Williams, Ashish M Kamat Current treatment options in oncology, February 2015; 1-19
  • The Effect of Concomitant Carcinoma in Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathologic Outcomes, But No Effect on Survival WP Parker, PL Ho, JJ Melquist, K Scott, JM Holzbeierlein, E Lopez-Corona, AM Kamat, EK Lee The Journal of Urology, November 11, 2014
  • Blocking PGE2-induced Tumor Repopulation Abrogates Bladder Cancer Chemoresistance Antonina V Kurtova, Jing Xiao, Qianxing Mo, Senthil Pazhanisamy, Ross Krasnow, Seth P. Lerner, Fengju Chen, Terrence T Roh, Erica Lay, Philip Levy Ho, Keith Syson Chan. Nature, December 3, 2014
  • Normal and Neoplastic Urothelial Stem Cells: Getting to the Root of the Problem. Philip Levy Ho, Antonina Kurtova, Keith Syson Chan. Nature Reviews Urology, October 9, 2012; 583-94 (10)
  • Stat3 Activation in Urothelial Stem Cells Leads to Direct Progression to Invasive Bladder Cancer Philip Levy Ho, Erica Julianne Lay, Weiguo Jian, Diana Parra, Keith Syson Chan Cancer Research, July 1, 2012; 72 (13)
  • Three Differentiation States Risk-stratify Bladder Cancer into Distinct Subtypes. Volkmer, Jens-Peter, Sahoo, Debashis, Chin, Robert, Ho, Philip, Tang, Chad, Kurtova, Antonina, Willingham, Stephen, Pazhanisamy, Senthil, Contreras-Trujillo, Humberto, Storm, Theresa, Lotan, Yair, Beck, Andrew, Chung, Benajmin, Alizadeh, Ash, Godoy, Guilherme, Lerner, Seth, van de Rijn, Matt, Shortliffe, Linda, Weissman, Irving, and Chan, Keith Proc Natl Acad Sci USA, February 7, 2012; 109 (6)
  • A 60-Year-Old Woman With an Incidentally Discovered Right Renal Mass Lambros Stamatakis, Philip J. Cheng, Philip L. Ho, Michael J. Thrall, Wesley A. Mayer, Brian J. Miles, and Richard E. Link Urology, December 2012; 1183-6 (6)​